Search Results
German Center for Diabetes Research (DZD), Neuherberg, Germany
Search for other papers by S J Brandt in
Google Scholar
PubMed
German Center for Diabetes Research (DZD), Neuherberg, Germany
Search for other papers by M Kleinert in
Google Scholar
PubMed
German Center for Diabetes Research (DZD), Neuherberg, Germany
Division of Metabolic Diseases, Technische Universität, Munich, Germany
Search for other papers by M H Tschöp in
Google Scholar
PubMed
German Center for Diabetes Research (DZD), Neuherberg, Germany
Search for other papers by T D Müller in
Google Scholar
PubMed
). For example, following Roux-en-Y gastric bypass, gastric banding or sleeve gastronomy, there is an increase in the secretion of glucagon-like peptide 1 (GLP-1) ( Laferrere 2016 , Meek et al. 2016 , Clemmensen et al. 2017 ), which is known not
Search for other papers by Nava Chapnik in
Google Scholar
PubMed
Search for other papers by Yoni Genzer in
Google Scholar
PubMed
Robert H. Smith Faculty of Agriculture, Fritz Haber Center for Molecular Dynamics, Food and Environment, Institute of Biochemistry, Food Science and Nutrition, The Hebrew University of Jerusalem, Rehovot 76100, Israel
Search for other papers by Avraham Ben-Shimon in
Google Scholar
PubMed
Robert H. Smith Faculty of Agriculture, Fritz Haber Center for Molecular Dynamics, Food and Environment, Institute of Biochemistry, Food Science and Nutrition, The Hebrew University of Jerusalem, Rehovot 76100, Israel
Search for other papers by Masha Y Niv in
Google Scholar
PubMed
Search for other papers by Oren Froy in
Google Scholar
PubMed
peptidomimetic compounds ( Arora & Ansari 2009 , Rubinstein & Niv 2009 ). We have recently designed novel and highly specific kinase-inhibiting peptides ( Niv et al . 2004 , Wexler et al . 2005 , Mack et al . 2008 , Rubinstein & Niv 2009 ) for the
Search for other papers by Rachel K Meyer in
Google Scholar
PubMed
BIO5 Institute, University of Arizona, Tucson, Arizona, USA
Search for other papers by Frank A Duca in
Google Scholar
PubMed
organ, maintaining energy and glucose homeostasis both directly and indirectly via gut peptides produced by enteroendocrine cells (EECs) and endocrine metabolites produced or altered by the gut microbiota ( Ahlman & Nilsson 2001 ). EECs are dispersed
Search for other papers by Xianxian Huang in
Google Scholar
PubMed
Search for other papers by Jing Liu in
Google Scholar
PubMed
Search for other papers by Guangquan Peng in
Google Scholar
PubMed
Search for other papers by Mingyue Lu in
Google Scholar
PubMed
Search for other papers by Zhongbo Zhou in
Google Scholar
PubMed
Search for other papers by Neng Jiang in
Google Scholar
PubMed
Search for other papers by Zhiming Yan in
Google Scholar
PubMed
, glucagon-like peptide 1; GIP, glucose-dependent insulinotropic peptide; GLP-1R, glucagon-like peptide 1 receptor; GIPR, glucose-dependent insulinotropic peptide receptor; GLP-1RA, glucagon-like peptide 1 receptor agonist; T2DM, type 2 diabetes mellitus
Search for other papers by Bernard Khoo in
Google Scholar
PubMed
Search for other papers by Tricia Mei-Mei Tan in
Google Scholar
PubMed
gut hormone path-finder Glucagon-like peptide 1 (GLP-1) is the most extensively studied gut hormone with translational and clinical evidence for its efficacy ( Holst 2007 ). It is an alternatively processed product of the proglucagon peptide
Search for other papers by Hans-Peter Holthoff in
Google Scholar
PubMed
Search for other papers by Kerstin Uhland in
Google Scholar
PubMed
Search for other papers by Gabor Laszlo Kovacs in
Google Scholar
PubMed
Search for other papers by Andreas Reimann in
Google Scholar
PubMed
Search for other papers by Kristin Adler in
Google Scholar
PubMed
Search for other papers by Clara Wenhart in
Google Scholar
PubMed
Search for other papers by Martin Ungerer in
Google Scholar
PubMed
this study, we only chose TSHR-Fc for in vivo experiments, since their purification is easiest, and epicutaneous antigen administration presumably favors presentation of processed peptides by Langerhans cells to T cells, and the amino acid sequence of
Search for other papers by David A Bechtold in
Google Scholar
PubMed
Search for other papers by Simon M Luckman in
Google Scholar
PubMed
Introduction The first recognised member of the RFamide neuropeptide family was the cardioexcitatory peptide, FMRFamide, isolated from ganglia of the clam Macrocallista nimbosa ( Price & Greenberg 1977 ). Since then a large number
Search for other papers by Shunbun Kita in
Google Scholar
PubMed
Search for other papers by Hitoshi Nishizawa in
Google Scholar
PubMed
Search for other papers by Yosuke Okuno in
Google Scholar
PubMed
Search for other papers by Masaki Tanaka in
Google Scholar
PubMed
Pharmaceutical Research Division, Department of Metabolic Medicine, Department of Medicine and Pathophysiology, Pharmacology Research Laboratories I, Takeda Pharmaceutical Company Ltd, Yodogawa-ku, Osaka 532-8686, Japan
Search for other papers by Atsutaka Yasui in
Google Scholar
PubMed
Search for other papers by Morihiro Matsuda in
Google Scholar
PubMed
Search for other papers by Yukio Yamada in
Google Scholar
PubMed
Pharmaceutical Research Division, Department of Metabolic Medicine, Department of Medicine and Pathophysiology, Pharmacology Research Laboratories I, Takeda Pharmaceutical Company Ltd, Yodogawa-ku, Osaka 532-8686, Japan
Search for other papers by Iichiro Shimomura in
Google Scholar
PubMed
( Nishizawa et al . 2004 , Yasui et al . 2007 ). The musclin protein contains a region homologous to members of the natriuretic peptide (NP) family, as well as a KKKR putative serine protease cleavage site, also characteristic of NP proteins ( Nishizawa et
Search for other papers by Maria Esteban-Lopez in
Google Scholar
PubMed
Biomolecular Science Institute, Florida International University, Miami, Florida, USA
Search for other papers by Alexander I Agoulnik in
Google Scholar
PubMed
Introduction RXFP2 (previously known as GREAT or LGR8) is a GPCR from the relaxin family peptide receptors, which also contains three other members: RXFP1, RXFP3, and RXFP4 ( Halls et al. 2007 b ). Relaxin is the cognate ligand for RXFP1 and
Department of Endocrinology, Christchurch School of Medicine and Health Sciences, University of Otago, PO Box 4345, 8140 Christchurch, New Zealand
Search for other papers by Angela S Bang in
Google Scholar
PubMed
Department of Endocrinology, Christchurch School of Medicine and Health Sciences, University of Otago, PO Box 4345, 8140 Christchurch, New Zealand
Search for other papers by Steven G Soule in
Google Scholar
PubMed
Department of Endocrinology, Christchurch School of Medicine and Health Sciences, University of Otago, PO Box 4345, 8140 Christchurch, New Zealand
Search for other papers by Tim G Yandle in
Google Scholar
PubMed
Department of Endocrinology, Christchurch School of Medicine and Health Sciences, University of Otago, PO Box 4345, 8140 Christchurch, New Zealand
Search for other papers by A Mark Richards in
Google Scholar
PubMed
Department of Endocrinology, Christchurch School of Medicine and Health Sciences, University of Otago, PO Box 4345, 8140 Christchurch, New Zealand
Search for other papers by Chris J Pemberton in
Google Scholar
PubMed
, Shiiya et al. 2002 ), suggesting that the n-octanoic acid moiety is rapidly degraded upon secretion from stomach cells. In the rat ( Hosoda et al. 2000 ), immunoreactive (IR) ghrelin(1–28) peptides are most abundant in the stomach, followed by the